Sheptide A: an antimalarial cyclic pentapeptide from a fungal strain in the Herpotrichiellaceae
- PMID: 37731043
- PMCID: PMC10602849
- DOI: 10.1038/s41429-023-00655-6
Sheptide A: an antimalarial cyclic pentapeptide from a fungal strain in the Herpotrichiellaceae
Abstract
As part of ongoing efforts to isolate biologically active fungal metabolites, a cyclic pentapeptide, sheptide A (1), was discovered from strain MSX53339 (Herpotrichiellaceae). The structure and sequence of 1 were determined primarily by analysis of 2D NMR and HRMS/MS data, while the absolute configuration was assigned using a modified version of Marfey's method. In an in vitro assay for antimalarial potency, 1 displayed a pEC50 value of 5.75 ± 0.49 against malaria-causing Plasmodium falciparum. Compound 1 was also tested in a counter screen for general cytotoxicity against human hepatocellular carcinoma (HepG2), yielding a pCC50 value of 5.01 ± 0.45 and indicating a selectivity factor of ~6. This makes 1 the third known cyclic pentapeptide biosynthesized by fungi with antimalarial activity.
© 2023. The Author(s).
Conflict of interest statement
The authors declare the following competing financial interest(s): NHO, CJP and HAR are members of the Scientific Advisory Board of Clue Genetics, Inc. NHO is also a member of the Scientific Advisory Boards of Mycosynthetix, Inc and Ionic Pharmaceuticals, LLC.
Figures
References
-
- World malaria report 2020: 20 years of global progress and challenges. World Health Organization: Geneva, 2020.
-
- World malaria report 2021. World Health Organization: Geneva, 2021.
-
- Aminake MN, Pradel G. Antimalarial drugs resistance in Plasmodium falciparum and the current strategies to overcome them. Microb Pathog Strateg Combating Them Sci Technol Educ. 2013;1:269–82.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials